Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |